Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysis.

Zunaira NaveedMusharraf SarwarZahid AliDanish SaeedKhadija ChoudhryPiero Schirò Zouina SarfrazMiguel FelixIvan Cherrez-Ojeda

Published in: Journal of clinical laboratory analysis (2022)

This study finds that anakinra is potentially a strong candidate as an anti-inflammatory agent to reduce mortality in COVID-19 patients, specifically in patients with elevated inflammatory biomarkers.

Keyphrases

sars cov
anti inflammatory
oxidative stress
cardiovascular events
risk factors
combination therapy
replacement therapy